209 related articles for article (PubMed ID: 36172403)
1. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
3. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
[TBL] [Abstract][Full Text] [Related]
4. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
5. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
7. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
Son BY; Cho S; Yum SW; Kim K; Jheon S
J Surg Oncol; 2018 Mar; 117(3):451-456. PubMed ID: 29127699
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
Uehara H; Tsutani Y; Okumura S; Nakayama H; Adachi S; Yoshimura M; Miyata Y; Okada M
Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765
[TBL] [Abstract][Full Text] [Related]
11. The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
Li R; Li Z; Yang Z; Qiu B; Tan F; Xue Q; Gao S; He J
Transl Lung Cancer Res; 2024 Feb; 13(2):256-268. PubMed ID: 38496684
[TBL] [Abstract][Full Text] [Related]
12. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
13. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
14. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
15. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes.
Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L
AJR Am J Roentgenol; 2024 May; ():. PubMed ID: 38809121
[No Abstract] [Full Text] [Related]
16. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
[TBL] [Abstract][Full Text] [Related]
17. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
Moon Y; Lee KY; Park JK
J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
[TBL] [Abstract][Full Text] [Related]
19. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
20. Role of PET/CT in Management of Early Lung Adenocarcinoma.
Shao X; Niu R; Jiang Z; Shao X; Wang Y
AJR Am J Roentgenol; 2020 Feb; 214(2):437-445. PubMed ID: 31714848
[No Abstract] [Full Text] [Related]
[Next] [New Search]